Cargando…

Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery

BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zariwala, M Gulrez, Bendre, Harshada, Markiv, Anatoliy, Farnaud, Sebastien, Renshaw, Derek, Taylor, Kevin MG, Somavarapu, Satyanarayana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166747/
https://www.ncbi.nlm.nih.gov/pubmed/30310283
http://dx.doi.org/10.2147/IJN.S166901
_version_ 1783360088990285824
author Zariwala, M Gulrez
Bendre, Harshada
Markiv, Anatoliy
Farnaud, Sebastien
Renshaw, Derek
Taylor, Kevin MG
Somavarapu, Satyanarayana
author_facet Zariwala, M Gulrez
Bendre, Harshada
Markiv, Anatoliy
Farnaud, Sebastien
Renshaw, Derek
Taylor, Kevin MG
Somavarapu, Satyanarayana
author_sort Zariwala, M Gulrez
collection PubMed
description BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transform infra-red (FT-IR) spectroscopy and proton NMR spectroscopy (H-NMR). Liposomes encapsulating ferrous sulphate as a model hydrophilic drug for intestinal delivery were prepared with or without OPC inclusion (Lipo-Fe and OPC-Lipo-Fe). RESULTS: Entrapment of iron was significantly higher in OPC containing liposomes compared to controls. Quantitative iron absorption from the OPC liposomes was significantly higher (1.5-fold P<0.05) than free ferrous sulphate controls. Qualitative uptake analysis by confocal imaging using coumarin-6 dye loaded liposomes also indicated higher cellular uptake and internalization of the OPC-containing liposomes. CONCLUSION: These findings suggest that addition of OPC during liposome preparation creates robust vesicles that have improved mucoadhesive and absorption enhancing properties. The chitosan derivative OPC therefore provides a novel alternative for formulation of delivery vehicles targeting intestinal absorption.
format Online
Article
Text
id pubmed-6166747
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61667472018-10-11 Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery Zariwala, M Gulrez Bendre, Harshada Markiv, Anatoliy Farnaud, Sebastien Renshaw, Derek Taylor, Kevin MG Somavarapu, Satyanarayana Int J Nanomedicine Original Research BACKGROUND: Encapsulation of hydrophilic drugs within liposomes can be challenging. METHODS: A novel chitosan derivative, O-palmitoyl chitosan (OPC) was synthesized from chitosan and palmitoyl chloride using methane-sulfonic acid as a solvent. The success of synthesis was confirmed by Fourier transform infra-red (FT-IR) spectroscopy and proton NMR spectroscopy (H-NMR). Liposomes encapsulating ferrous sulphate as a model hydrophilic drug for intestinal delivery were prepared with or without OPC inclusion (Lipo-Fe and OPC-Lipo-Fe). RESULTS: Entrapment of iron was significantly higher in OPC containing liposomes compared to controls. Quantitative iron absorption from the OPC liposomes was significantly higher (1.5-fold P<0.05) than free ferrous sulphate controls. Qualitative uptake analysis by confocal imaging using coumarin-6 dye loaded liposomes also indicated higher cellular uptake and internalization of the OPC-containing liposomes. CONCLUSION: These findings suggest that addition of OPC during liposome preparation creates robust vesicles that have improved mucoadhesive and absorption enhancing properties. The chitosan derivative OPC therefore provides a novel alternative for formulation of delivery vehicles targeting intestinal absorption. Dove Medical Press 2018-09-27 /pmc/articles/PMC6166747/ /pubmed/30310283 http://dx.doi.org/10.2147/IJN.S166901 Text en © 2018 Zariwala et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zariwala, M Gulrez
Bendre, Harshada
Markiv, Anatoliy
Farnaud, Sebastien
Renshaw, Derek
Taylor, Kevin MG
Somavarapu, Satyanarayana
Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title_full Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title_fullStr Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title_full_unstemmed Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title_short Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
title_sort hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166747/
https://www.ncbi.nlm.nih.gov/pubmed/30310283
http://dx.doi.org/10.2147/IJN.S166901
work_keys_str_mv AT zariwalamgulrez hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT bendreharshada hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT markivanatoliy hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT farnaudsebastien hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT renshawderek hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT taylorkevinmg hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery
AT somavarapusatyanarayana hydrophobicallymodifiedchitosannanoliposomesforintestinaldrugdelivery